This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chang Chun Petrochemical Co., Ltd., Chang Chun Plastics Co., Ltd., National Tsing Hua University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Li-Yu Sung
Introduction
Li-Yu Sung is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of genome editing, particularly through his innovative work with the CRISPR/Cas system. His research has the potential to revolutionize genetic engineering and biotechnology.
Latest Patents
Li-Yu Sung holds 1 patent related to a Cas9 expression plasmid, which is a crucial component of a genome editing system. This patent includes a tracrRNA sequence, a Cas9 gene, and a chloramphenicol resistance gene (Cm). The plasmid is designed to be applied in a CRISPR/Cas-coupled λ-red recombineering system, enabling high-efficiency genome editing.
Career Highlights
Throughout his career, Li-Yu Sung has worked with notable institutions, including National Tsing Hua University and Chang Chun Plastics Co., Ltd. His work has garnered attention for its innovative approach to genetic modification and its implications for various scientific fields.
Collaborations
Li-Yu Sung has collaborated with several talented individuals, including I-Hsin Yeh and Yu Chen Hu. These partnerships have contributed to the advancement of his research and the development of new technologies in genome editing.
Conclusion
Li-Yu Sung's contributions to the field of genome editing through his innovative patent and collaborations highlight his role as a leading inventor in biotechnology. His work continues to pave the way for advancements in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile